//3 mins read
A new study has found that gene therapy using nanocarriers derived from mouse connective-tissue cells can repair damaged spinal discs and alleviate pain in mice. This approach, which involves injecting genetic material to promote tissue regeneration, shows potential as a sustainable alternative to opioids for treating back pain. It could also enhance healing during surgical procedures, according to the researchers from The Ohio State University. Future research will extend to older animal models and, eventually, clinical trials.